relative to requiring insurance coverage for glucose monitoring devices for people with diabetes.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 11 Sponsors 7

Oct 31, 2024 · House

Interim Study Report: Not Recommended for Future Legislation (Vote 14-2)

Sep 25, 2024 · House

Executive Session: 10/17/2024 10:00 am LOB 302-304

Sep 19, 2024 · House

Subcommittee Work Session: 09/24/2024 11:00 am LOB 302-304

Aug 14, 2024 · House

Full Committee Work Session: 09/12/2024 10:00 am LOB 302-304

Mar 28, 2024 · House

Refer for Interim Study: MA VV 03/28/2024 HJ 10 P. 17

Mar 18, 2024 · House

Committee Report: Refer for Interim Study 03/13/2024 (Vote 18-0; CC) HC 12 P. 9

Mar 7, 2024 · House

Executive Session: 03/13/2024 10:00 am LOB 302-304

Feb 14, 2024 · House

Subcommittee Work Session: 02/20/2024 10:00 am LOB 305

Feb 7, 2024 · House

Subcommittee Work Session: 02/14/2024 10:00 am LOB 302-304

Jan 9, 2024 · House

Public Hearing: 01/18/2024 11:15 am LOB 302-304

Dec 15, 2023 · House

Introduced 01/03/2024 and referred to Commerce and Consumer Affairs HJ 1 P. 25

PASSAGE PROBABILITY

24.7% Unlikely

Why this number

Stage base In Committee — base rate 27%, measured from NH's completed sessions
Momentum -0 49/100 from the pace of recorded action
Time since last action -22 709 days quiet
Cosponsors +8 6 signed on
Bipartisan support +9 4 D · 3 R
Sponsor influence +3 78/100

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.